DFTX — Definium Therapeutics, Inc. stock price, charts and financials

QT91Definium Therapeutics, Inc.

Definium Therapeutics, Inc. (NASDAQ: DFTX) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
42.32
+0.53+1.27%
OverviewShort InterestFilings
DFTXQT91Definium Therapeutics, Inc.·NASDAQ
42.32+1.27%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jun 26, 20264Statement of changes in beneficial ownership
Jun 26, 20264Statement of changes in beneficial ownership
Jun 26, 20264Statement of changes in beneficial ownership
Jun 26, 20264Statement of changes in beneficial ownership
Jun 26, 20264Statement of changes in beneficial ownership
Jun 24, 20268-KCurrent report
Jun 24, 2026424B5Prospectus
Jun 22, 20268-KCurrent report
Jun 22, 20264Statement of changes in beneficial ownership
Jun 22, 20264Statement of changes in beneficial ownership
Jun 22, 20264Statement of changes in beneficial ownership
Jun 22, 20264Statement of changes in beneficial ownership
Jun 22, 20264Statement of changes in beneficial ownership
Jun 22, 2026424B5Prospectus
Jun 16, 2026S-8Registration of employee benefit securities
Jun 15, 20264Statement of changes in beneficial ownership
Jun 15, 20264Statement of changes in beneficial ownership
Jun 15, 20264Statement of changes in beneficial ownership
Jun 15, 20264Statement of changes in beneficial ownership
Jun 15, 20264Statement of changes in beneficial ownership
Jun 15, 20264Statement of changes in beneficial ownership
Jun 12, 20268-KCurrent report
May 19, 20268-KCurrent report
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 12, 20268-KCurrent report
#1 / 25 of 441
Page
▼
/ 18